Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Acquisition
Pharma
Shionogi acquires IntraBio to bolster rare disease business
Shionogi is scooping up IntraBio and its lead asset, Aqneursa, in a $2 billion deal just weeks after IntraBio's key FDA label expansion.
Donavyn Coffey
Oct 5, 2026 11:33am
Boehringer Ingelheim divests biologics CDMO unit in China
Sep 24, 2026 11:38am
McKesson acquires Maryland CRO for $2.25 billion
Aug 25, 2026 11:22am
CG Life joins forces with The Considered+AI
Jul 29, 2026 8:00am
After trial fail, Teravance is bought out by Zymeworks for $929M
Jun 29, 2026 11:30am
Esperion to go private in potential $1.1B buyout by ArchiMed
May 1, 2026 11:26am
